Protea Announces Research Collaboration With Oak Ridge National Laboratory / UT-Battelle
Protea Biosciences, Inc.
24.02.2012 12:30
---------------------------------------------------------------------------
Oak Ridge Installs Protea's LAESI DP-1000 Ionization System
MORGANTOWN, W.Va., 2012-02-24 12:30 CET (GLOBE NEWSWIRE) --
Protea Biosciences Group, Inc. ('Protea'), a leading bioanalytics company,
announced today it had begun a research collaboration with the laboratory of
Gary J. Van Berkel, Ph.D., Distinguished Research Staff and Group Leader,
Organic and Biological Mass Spectrometry Group, in the Chemical Sciences
Division, at Oak Ridge National Laboratory, located in Oak Ridge Tennessee.
Under terms of the research collaboration, a LAESI DP-1000 ionization system,
based on Protea's proprietary technology will be used by the Van Berkel
laboratory to explore the molecular structures of material surfaces. The two
parties will jointly publish research results and Protea will have certain
rights to the discoveries resulting from the collaboration.
Oak Ridge National Laboratory (ORNL) is the largest science and energy national
laboratory in the U.S. Department of Energy system, employing 1600 scientists
and engineers. ORNL's scientific programs focus on materials, neutron science,
energy, high-performance computing, systems biology and national security.
'We are honored to commence this research collaboration with the Van Berkel
laboratory at Oak Ridge,' stated Steve Turner, Protea's Chairman & CEO. 'Their
team has been responsible for many innovations in the field of surface
profiling. We believe the combination of their laboratory's expertise with the
revolutionary capabilities of the LAESI technology will generate exciting
results for life science research.'
Dr. Van Berkel commented, 'There has been a great need for new technology that
ionizes samples with no sample preparation, so that material surfaces can be
analyzed rapidly and without bias under ambient conditions. This product has
the potential to make a real contribution to the future of surface profiling
and imaging mass spectrometry.'
In 2011, Protea completed the development of the first instruments to embody
LAESI technology. By eliminating pretreatment steps, samples can be analyzed
without the possible contamination, bias or sample loss that occurs with the
current techniques, which require the introduction of chemicals,
chromatographic separations, or the destruction of the sample itself, in order
to enable the identification and characterization of material surfaces by mass
spectrometry.
LAESI technology was invented in the laboratory of Akos Vertes, PhD., Professor
of Chemistry, Professor of Biochemistry & Molecular Biology Founder and
Co-director W.M. Keck Institute for Proteomics Technology and Applications
Department of Chemistry, George Washington University, and exclusively licensed
to Protea.
Protea is a leader in the field of Bioanalytics -- the identification and
characterization of proteins, metabolites, and other biomolecules, which are
the products of all living cells and life forms -- technology that is
foundational for all pharmaceutical and life science research.
Forward-Looking Statements
This press release may contain certain statements relating to future results
which are forward-looking statements. These statements are not historical
facts, but instead represent only the Company's belief regarding future events,
many of which, by their nature, are inherently uncertain and outside of the
Company's control. It is possible that the Company's actual results and
financial condition may differ, possibly materially, from the anticipated
results and financial condition indicated in these forward-looking statements.
Further information concerning the Company and its business, including factors
that potentially could materially affect the Company's financial results, are
contained in the Company's filings with the Securities and Exchange Commission.
All forward-looking statements included in this press release are made only as
of the date of this press release, and we do not undertake any obligation to
publicly update or correct any forward-looking statements to reflect events or
circumstances that subsequently occur or of which we hereafter become aware.
CONTACT: Protea Biosciences Group, Inc.
955 Hartman Run Road
Morgantown, WV 26507
Phone: 304.284.2600
Fax: 304.292.7101
stephen.turner@proteabio.com
Protea website: www.proteabio.com
About LAESI: https://proteabio.com/LAESI
Oak Ridge National Laboratory website: www.ornl.gov/
News Source: NASDAQ OMX
24.02.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Protea Biosciences, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US9900524250
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Protea Biosciences, Inc.
24.02.2012 12:30
---------------------------------------------------------------------------
Oak Ridge Installs Protea's LAESI DP-1000 Ionization System
MORGANTOWN, W.Va., 2012-02-24 12:30 CET (GLOBE NEWSWIRE) --
Protea Biosciences Group, Inc. ('Protea'), a leading bioanalytics company,
announced today it had begun a research collaboration with the laboratory of
Gary J. Van Berkel, Ph.D., Distinguished Research Staff and Group Leader,
Organic and Biological Mass Spectrometry Group, in the Chemical Sciences
Division, at Oak Ridge National Laboratory, located in Oak Ridge Tennessee.
Under terms of the research collaboration, a LAESI DP-1000 ionization system,
based on Protea's proprietary technology will be used by the Van Berkel
laboratory to explore the molecular structures of material surfaces. The two
parties will jointly publish research results and Protea will have certain
rights to the discoveries resulting from the collaboration.
Oak Ridge National Laboratory (ORNL) is the largest science and energy national
laboratory in the U.S. Department of Energy system, employing 1600 scientists
and engineers. ORNL's scientific programs focus on materials, neutron science,
energy, high-performance computing, systems biology and national security.
'We are honored to commence this research collaboration with the Van Berkel
laboratory at Oak Ridge,' stated Steve Turner, Protea's Chairman & CEO. 'Their
team has been responsible for many innovations in the field of surface
profiling. We believe the combination of their laboratory's expertise with the
revolutionary capabilities of the LAESI technology will generate exciting
results for life science research.'
Dr. Van Berkel commented, 'There has been a great need for new technology that
ionizes samples with no sample preparation, so that material surfaces can be
analyzed rapidly and without bias under ambient conditions. This product has
the potential to make a real contribution to the future of surface profiling
and imaging mass spectrometry.'
In 2011, Protea completed the development of the first instruments to embody
LAESI technology. By eliminating pretreatment steps, samples can be analyzed
without the possible contamination, bias or sample loss that occurs with the
current techniques, which require the introduction of chemicals,
chromatographic separations, or the destruction of the sample itself, in order
to enable the identification and characterization of material surfaces by mass
spectrometry.
LAESI technology was invented in the laboratory of Akos Vertes, PhD., Professor
of Chemistry, Professor of Biochemistry & Molecular Biology Founder and
Co-director W.M. Keck Institute for Proteomics Technology and Applications
Department of Chemistry, George Washington University, and exclusively licensed
to Protea.
Protea is a leader in the field of Bioanalytics -- the identification and
characterization of proteins, metabolites, and other biomolecules, which are
the products of all living cells and life forms -- technology that is
foundational for all pharmaceutical and life science research.
Forward-Looking Statements
This press release may contain certain statements relating to future results
which are forward-looking statements. These statements are not historical
facts, but instead represent only the Company's belief regarding future events,
many of which, by their nature, are inherently uncertain and outside of the
Company's control. It is possible that the Company's actual results and
financial condition may differ, possibly materially, from the anticipated
results and financial condition indicated in these forward-looking statements.
Further information concerning the Company and its business, including factors
that potentially could materially affect the Company's financial results, are
contained in the Company's filings with the Securities and Exchange Commission.
All forward-looking statements included in this press release are made only as
of the date of this press release, and we do not undertake any obligation to
publicly update or correct any forward-looking statements to reflect events or
circumstances that subsequently occur or of which we hereafter become aware.
CONTACT: Protea Biosciences Group, Inc.
955 Hartman Run Road
Morgantown, WV 26507
Phone: 304.284.2600
Fax: 304.292.7101
stephen.turner@proteabio.com
Protea website: www.proteabio.com
About LAESI: https://proteabio.com/LAESI
Oak Ridge National Laboratory website: www.ornl.gov/
News Source: NASDAQ OMX
24.02.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Protea Biosciences, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US9900524250
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------